Caricamento...
Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis
INTRODUCTION: Atopic dermatitis (AD) is a recurrent, pruritic inflammatory skin disease with complex immunopathogenesis characterized by a dominant T(H)2 response. Dupilumab is an interleukin (IL)-4 receptor alpha antagonist that subsequently blocks IL-4 and IL-13 signaling. It has recently been app...
Salvato in:
| Pubblicato in: | Core Evid |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5826246/ https://ncbi.nlm.nih.gov/pubmed/29503598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S133661 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|